Phase IIa study of SNJ-1656; An exploration study in patients with primary open angle glaucoma or ocular hypertensio
Not Applicable
- Conditions
- Primary open-angle glaucoma (POAG) or Ocular hypertension (OH)
- Registration Number
- JPRN-UMIN000009648
- Lead Sponsor
- Senju Pharmaceutical co.,ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Any active ocular disease other than glaucoma or OH 2)Active retinal disease 3)Ocular surgery within 3 months 4)History of keratorefractive surgery or filtering surgery 5)History of trabeculotomy in the study eye 6)Anticipated wearing of contact lenses 7)Uncontrolled systemic disease (eg, hepatic, renal, cardiovascular or endocrine system disease) 8)Women who were pregnant, nursing or who were of childbearing potential, or planning a pregnancy 9)Highly visual field loss (eg, the mean deviation <=15dB) 10)Corneal abnormalities that would preclude accurate readings with an applanation tonometer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method